MDCX
Medicus Pharma Ltd. Common StockNASDAQHealthcare$0.45+6.43%ClosedMarket Cap: $9.9M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
-250.78
P/S
0.00
EV/EBITDA
-0.26
DCF Value
$0.08
FCF Yield
-192.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-2986.8%
ROA
-451.4%
ROIC
-582.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $0.00 | $-5.9M | $-0.43 |
| FY 2025 | $0.00 | $-25.4M | $-1.96 |
| Q3 2025 | $0.00 | $-16.0M | $-1.12 |
| Q2 2025 | $0.00 | $-6.2M | $-0.43 |
Analyst Ratings
View AllD. Boral CapitalBuy
2026-03-19D. Boral CapitalBuy
2025-12-15D. Boral CapitalBuy
2025-11-13D. Boral CapitalBuy
2025-09-29D. Boral CapitalBuy
2025-08-22Trading Activity
Insider Trades
View AllBrennan Edward J.officer: Chief Scientific Officer
SellWed Apr 01
Smith Andrew Alasdairofficer: Chief Operating Officer
SellWed Apr 01
Rodgers Cathy McMorrisdirector
SellWed Apr 01
Raju Ajaydirector
SellWed Apr 01
Mehmud Faisalofficer: Chief Medical Officer
SellWed Apr 01
Company Info
Sector
Healthcare
Industry
—
Country
CA
Exchange
NASDAQ
Beta
-0.04
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.